Biotechnology Focus web site and magazine are an essential source of news on everything from business and regulation to research and development in the Canadian life sciences industry. With the driving goal of furthering the understanding of the Canadian life sciences industry, Biotechnology Focus offers a medium where principal investigators, entrepreneurs and life sciences executives can find advice, insights, and inspiration on how to best run and grow their businesses. As the leading forum for the industry in Canada, we can help you connect with the life sciences market through a full suite of communications and marketing products. We offer both print and online media services, including blogs, newsletters, social media outreach and events. Visit http://biotechnologyfocus.ca to learn more.
PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
Montréal InVivo is an economic development organization dedicated to the creation of a business environment that fosters innovation and growth of companies and organizations in the life sciences and health technologies (LSHT) sector. Montréal InVivo provides strategic leverage and initiates and coordinates key actions to collectively seize development opportunities facing the cluster. Montreal InVivo’s cluster represents the life sciences and health technologies (LSHT) of Metropolitan Montreal. This cluster is composed of nearly 620 organizations, including more than 150 research centers and 80 subsidiaries of world-class companies and 41,000 people working in the sector. This cluster generating great ideas includes four universities and ranks first in Canada for the number of research centers. The cluster assumes a leadership role in rallying players around common goals aimed at ensuring the growth and competitiveness of LSHT in Greater Montréal and throughout Québec.
Biotechgate is a global Life Science Database containing over 30’000 company profiles and providing the user with information on available licensing products, financing rounds, key management, technology platforms and more. The development of the database started in 2003 with the launch of the Swiss Life Science Database. Due to the success of this first database, the global platform www.biotechgate.com was launched in 2004. The Biotechgate Database is property of Swiss based Venture Valuation AG. All the profiles in the database are constantly updated by a dedicated team of analysts. In addition, Biotechgate cooperates with more than 30 industry associations and development agencies. You can see the entire list of our partners here. For the content provided in the Licensing Deals Database, Biotechgate cooperates with Dutch based PharmaPlus, whereas the information provided in the Investor Database is provided by US based Life Science Nation
BIOQuébec is committed to supporting Québec’s biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone’s health and quality of life. Our mission is to position Québec, on an international scale, as an undeniable key player in the biotechnology and life sciences field.
BioTalent Canada is the HR partner of Canada’s bio-economy. As an HR expert and national non-profit organization, BioTalent Canada focuses on building partnerships and skills for Canada’s bio-economy to ensure the industry has access to job-ready people. Through projects, research and product development BioTalent Canada connects employers with job seekers, delivers human resource information and skills development tools so the industry can focus on strengthening Canada’s biotech business. For more information, please visit biotalent.ca
The Clinical Research Association of Canada is a non-profit group of professional volunteers. The association provides a forum for discussion and exchange of ideas relevant to all aspects of pharmaceutical, biotechnology and device clinical research.
Vantage BioTrials Inc. is a privately-held, CRO that provides Phase I-IV clinical trial management services to international pharmaceutical, biotechnology, generic pharmaceutical and medical device companies within North America and Europe. We are one of the only Canadian CROs named as an “Emerging Pharma Leader” by Pharmaceutical Executive Magazine for its lean management style and effectiveness in realizing project goals. Experts in implementing Risk-Based Management through the use of Quality by Design (QbD) methodologies, we accelerate the conduct of a study and reduce overall risk. As a result this ensures that your trial is performed correctly, the first time! Feel free to download Vantage BioTrials’ corporate presentation (PDF) which further explains our background and business model and highlights our expertise, or visit www.vantagebiotrials.com for more information.
CATALIS is the end result of the Early Stage Clinical Trials initiative, an extensive project introduced by Montréal InVivo and its members to ensure that Québec’s clinical research industry is recognized on a global scale by favoring private investments and maximizing human, economic, and social benefits. Now supported by CQDM, this project is funded by the Québec government and by four pharmaceutical companies: Abbvie, GSK, Pfizer, and Servier. Backed by these partners and supported by a critical mass of Québec’s public and private clinical research organizations, CATALIS has three objectives: making Québec an internationally recognized centre for initiating, designing, conducting, and analyzing early stage clinical trials, providing Québec patients access to innovative interventions, and assisting in the successful development of promising new drugs and health technology. For more information about this major project, go to www.catalisquebec.com
Québec has maintained an office in New England since 1970, recognizing the region’s importance as a neighbour and a partner in a wide array of sectors. The Québec Government Office in Boston’s mandate is to defend and promote Québec’s interests throughout the region and to foster economic, political, artistic, academic and institutional exchanges with the six New England states.